FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely hepatology, and may be used for treating patients with hepatic cirrhosis. That is ensured by prescribing Essentiale Forte N as a hepatoprotective agent, detoxification agents, enzymes, diuretics, hemostatic preparations, vitamins B1, B6, C. The probiotic Linex is additionally taken. If observing Child Pugh A and B hepatic cirrhosis, a dosage is 2 capsules 3 times a day. In Child Pugh A disease, the length of the treatment is 6 weeks, while Child Pugh B requires 7 weeks of the treatment. The stage of Child Pugh C hepatic cirrhosis provides taking 3 capsules 3 times a day. The length of the treatment makes 8-9 weeks.
EFFECT: method provides the higher clinical effectiveness ensured by a differentiated approach depending on the stage of hepatic cirrhosis.
2 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PATIENTS WITH CHRONIC LIVER DISEASES IN STAGE OF LATENCY AND DEGREE I MANIFESTED STAGE OF HEPATIC ENCEPHALOPATHY | 2011 |
|
RU2462251C1 |
METHOD FOR PREDICTION OF FATAL OUTCOMES IN PATIENTS SUFFERING VIRAL OR ALCOHOLIC CIRRHOSIS | 2011 |
|
RU2465818C1 |
METHOD OF TREATING PATIENTS WITH INTESTINAL DYSBACTERIOSIS | 2009 |
|
RU2400235C1 |
USE OF PREPARATION LAENNEK FOR TREATING CIRRHOSIS | 2015 |
|
RU2599040C1 |
METHOD OF TREATING PATIENTS WITH INTESTINAL DISBACTERIOSIS | 2014 |
|
RU2571495C1 |
PHARMACEUTICAL COMPOSITION BASED ON HEPATOPROTECTOR AND PREBIOTIC AND METHOD FOR PRODUCING AND APPLYING THE COMPOSITION | 2006 |
|
RU2318538C1 |
METHOD FOR TREATING HEPATIC CIRRHOSIS | 2000 |
|
RU2165775C1 |
METHOD OF COMPLEX TREATMENT OF THEURAPEITICALLY REFRACTORY SITUATIONAL DEPRESSIONS | 2006 |
|
RU2338543C2 |
MEDICATION FOR TREATING INTESTINAL DYSBIOSIS IN PATIENTS WITH CHRONIC CRYPTOGENIC HEPATITIS | 2009 |
|
RU2411955C1 |
INTEGRATED TREATMENT METHOD OF INTESTINE DYSBACTERIOSIS | 2007 |
|
RU2337697C1 |
Authors
Dates
2014-03-20—Published
2012-08-21—Filed